Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633126 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age
A Phase 1 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00633126: Completed Phase 1 study, sponsored by Forest Laboratories.
NCT00633126 is a Phase 1 study that has completed, run by Forest Laboratories. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00633126, a Phase 1 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects
Primary Outcome
The maximum plasma concentration (Cmax ) occurred around the time of the end of study drug infusion.
Interventions
- DRUG ceftaroline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
What the finished NCT00633126 record still lists
NCT00633126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which ceftaroline is the first listed.
NCT00633126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00633126 about?
NCT00633126 is a clinical study titled "Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age". The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects
What is the current status of trial NCT00633126?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2008-03. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00633126?
The interventions under investigation include: ceftaroline (DRUG).
Who is sponsoring clinical trial NCT00633126?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00633126's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia